EUVIMEDOpdag EUVIMED
Open access · CC BY 4.0

Investigation of the In Vitro and In Silico Anticancer Potential of Novel 4‐Arylthiazole‐Hydrazone Derivatives

Zeynep Zişan Demirci, Erol Akgün iD, Gülşen Akalın Çiftçi iD, Leyla Yurttaş iD

Chemical Biology & Drug Design · 2026

DOI: 10.1111/cbdd.70387 ↗

At a glance

Journal article in Chemical Biology & Drug Design, 2026. Written by Zeynep Zişan Demirci and 3 co-authors. Institution: Department of Pharmaceutical Chemistry, Institute of Graduate Education, Anadolu University, Eskişehir, Turkey. Major MEDLINE topics: Hydrazones, Antineoplastic Agents, Thiazoles. 37 references. The full text is freely available (open access, CC BY 4.0).

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

The anticancer efficacy of 4‐aryl‐2‐hydrazinothiazole derivatives, which combine a thiazole known for its wide range of medicinal applications and a hydrazide/hydrazone structure known for its unique biological properties, has been determined in numerous studies. In this study, novel 2‐[4‐[(2‐(4‐substituted thiazol‐2‐yl)hydrazono)methyl]phenoxy]acetic acid derivatives ( 2a–l ) were synthesized and evaluated for their anticancer activity in MCF‐7 breast cancer, A549 lung cancer, and L929 normal cell lines using cytotoxicity, apoptosis, and caspase‐3 activation assays. The compounds were found to exhibit high cytotoxicity, particularly showing more selective and high‐potential antiproliferative activity on the MCF‐7 cell line. In apoptosis studies, compounds 2c , 2d , and 2h caused programmed cell death in MCF‐7 cells exceeding 24%, close to cisplatin. Among these compounds, the derivative 2c containing 4‐methoxyphenyl caused caspase‐3 activation at a level similar to cisplatin. To conduct in silico studies of the compounds, molecular docking studies with the (4QTX) caspase‐3 enzyme, molecular dynamics simulation for three compounds ( 2d , 2g and 2l ), and Density Functional Theory (DFT) studies were performed. These studies have shown that the carboxylate groups in the compounds form strong and stable interactions with Arg64 and Arg207.

Subjects

MeSH terms (MEDLINE)

HydrazonesAntineoplastic AgentsThiazolesHumansApoptosisMolecular Docking SimulationCaspase 3MCF-7 CellsMolecular Dynamics SimulationCell Line, TumorCell Proliferation

Author keywords

A549DFT studiesMCF‐7apoptosiscaspase‐3 activationcytotoxcityhydrazonemolecular dynamics simulationmoleuclar dockingthiazole

Substances

HydrazonesAntineoplastic AgentsThiazolesCaspase 3

Authors and institutions

  • Department of Pharmaceutical Chemistry, Institute of Graduate Education, Anadolu University, Eskişehir, Turkey.
  • Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Marmara University, İstanbul, Turkey.
  • Department of Biohemistry, Faculty of Pharmacy, Anadolu University, Eskişehir, Turkey.
  • Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Anadolu University, Eskişehir, Turkey.

ORCID profiles: Erol Akgün, Gülşen Akalın Çiftçi, Leyla Yurttaş

Cite

APA

Demirci, Z. Z., Akgün, E., Çiftçi, G. A., & Yurttaş, L. (2026). Investigation of the In Vitro and In Silico Anticancer Potential of Novel 4‐Arylthiazole‐Hydrazone Derivatives. Chemical Biology & Drug Design. https://doi.org/10.1111/cbdd.70387

Vancouver

Demirci ZZ, Akgün E, Çiftçi GA, Yurttaş L. Investigation of the In Vitro and In Silico Anticancer Potential of Novel 4‐Arylthiazole‐Hydrazone Derivatives. Chemical Biology & Drug Design. 2026. doi:10.1111/cbdd.70387

BibTeX
@article{Demirci2026,
  author = {Demirci, Zeynep Zişan and Akgün, Erol and Çiftçi, Gülşen Akalın and Yurttaş, Leyla},
  title = {Investigation of the In Vitro and In Silico Anticancer Potential of Novel 4‐Arylthiazole‐Hydrazone Derivatives},
  journal = {Chemical Biology & Drug Design},
  year = {2026},
  doi = {10.1111/cbdd.70387}
}
Start for free →